News Release
- June 8, 2010
RELEASE OF "MUCODYNE® DS50%"
- January 18, 2010
MARKETING APPROVAL FOR "MUCODYNE® DS50%"
- January 7, 2010
Application filed for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder
- November 5, 2009
Execution of License Agreement on Neramexane for Tinnitus with Merz Pharmaceuticals for Japan Territory
- September 29, 2009
KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos® Tablets in China, India, Sri Lanka and ASEAN Countries
- July 27, 2009
Grant of Marketing Right to Senju Pharmaceutical on Gatifloxacin Ophthalmic Solution in China
- April 3, 2009
Change of Representative Director and President at KYORIN Pharmaceutical
- February 27, 2009
Execution of Licensing and Supply Agreement on Uritos® Tablets with SPIMACO
- January 29, 2009
Paper on Clinical Trial of MUCODYNE® for COPD Patients (PEACE Study) Chosen for THE LANCET Paper of the Year 2008
- December 24, 2008
Approval for an additional regimen and dose of Pentasa®for the treatment of ulcerative colitis in its active phase
- October 1, 2008
Launch of Ulcerative Colitis and Crohn's Disease Therapeutic Agent Pentasa Tablets 500
- September 30, 2008
Discontinuation of Commercialization of Gatiflo(gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan
- August 20, 2008
Results of Overseas Clinical Studies for KRP-104, anti-diabetes agent
- April 22, 2008
Execution of License Agreement on Flutiform, an Anti-asthmatic Treatment, in Japan
- April 18, 2008
Launch of KIPRES Tablets 5mg
- March 3, 2008
Pentasa Tablets 250 Received Approvals For Additional Pediatric Indication
- February 21, 2008
Results of Analysis of the OASIS Study,a Large-Scale Health-Related QOL Study in Patients with Chronic Cerebral Infarction
- January 30, 2008
Execution of an Exclusive Patent License and Collaborative Research and Development Agreement with Merck & Co.,Inc. in the Field of Infectious Diseases
- January 25, 2008
KIPRES Received Approvals for Additional Indication to Relieve Symptoms of Allergic Rhinitis
- October 12, 2007
Discontinuation of Cooperation on Baynas Marketing for Treatment of Allergic Rhinitis by Kyorin Pharmaceutical Co.,Ltd. and Bayer Yakuhin,Ltd.
1
2
3
4
Page Top
